World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
24799
World Ranking
1444
National Ranking
52

Medicine

D-Index
83
Citations
25766
World Ranking
15586
National Ranking
594

Maria Prins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Maria Prins sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 411 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Maria Prins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Maria Prins sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Maria Prins is a researcher affiliated with the University of Amsterdam in the Netherlands. Their primary field of study is Medicine, with a significant focus on Infectious Diseases, Epidemiology, and Hepatology. The work is mainly concentrated in the areas of HIV/AIDS research, drug use-related sexual risk behaviors, hepatitis C virus research, and COVID-19 clinical studies.

The scientist's research spans multiple interconnected topics, including:

  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • Hepatitis C Virus Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Sex Work and Related Issues

Recent publications by Maria Prins include:

  • "Seasonal coronavirus protective immunity is short-lasting," 2020, Nature Medicine
  • "Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis," 2021, The Lancet Public Health
  • "Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset," 2021, Clinical Infectious Diseases
  • "Coronavirus protective immunity is short-lasting," 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • "Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study," 2022, PLoS Medicine

The researcher collaborates regularly with a set of frequent co-authors, demonstrating active engagement in collaborative scientific efforts. Notable co-authors include:

  • Anders Boyd
  • Elske Hoornenborg
  • Udi Davidovich
  • Maarten F. Schim van der Loeff
  • Liza Coyer

Maria Prins publishes extensively in various scientific journals and platforms. The most frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS ONE
  • AIDS
  • SSRN Electronic Journal
  • Harvard Dataverse

Best Publications

  • Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

    M M Koopman;P Prandoni;F Piovella;P A Ockelford

  • Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

    Mette D. Hazenberg;Sigrid A. Otto;Birgit H. B. Van Benthem;Marijke Th. L. Roos

  • Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study

    Judith Schouten;Ferdinand W. Wit;Ineke G. Stolte;Neeltje A. Kootstra

  • Seasonal coronavirus protective immunity is short-lasting.

    Arthur W. D. Edridge;Joanna Kaczorowska;Alexis C. R. Hoste;Margreet Bakker

  • Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

    M. Levi;M. E. Cromheecke;E. De Jonge;M. H. Prins

  • Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

    A Babiker;S Darby;D De Angelis;D Kwart

  • Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

    Charlotte Van Den Berg;Colette Smit;Giel Van Brussel;Roel Coutinho

  • Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison

    M. E. Cromheecke;M. Levi;L. P. Colly;B. J. M. De Mol

  • Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

    A.M. de Roda Husman;M. Koot;M.T.E. Cornelissen;I.P.M. Keet

  • Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission

    Thijs J.W. Van De Laar;Akke K. Van Der Bij;Maria Prins;Sylvia M. Bruisten

  • Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection.

    Thijs J W van de Laar;Gail V Matthews;Maria Prins;Mark Danta

  • Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

    Benoît Marin;Rodolphe Thiébaut;Heiner C. Bucher;Virginie Rondeau

  • Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection.

    N H Dukers;J Goudsmit;J B de Wit;M Prins

  • Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.

    Colette Smit;Ronald Geskus;Sarah Walker;Caroline Sabin

  • Unravelling the impact of ethnicity on health in Europe: the HELIUS study

    Karien Stronks;Marieke B Snijder;Ron J G Peters;Maria Prins

  • Cohort profile: the Healthy Life in an Urban Setting (HELIUS) study in Amsterdam, The Netherlands

    Marieke B Snijder;Henrike Galenkamp;Maria Prins;Eske M Derks

  • Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention

    Lucas Wiessing;Marica Ferri;Bart Grady;Maria Kantzanou

  • A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.

    Daniela Bezemer;Frank de Wolf;Maarten C Boerlijst;Ard van Sighem

  • Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.

    Hans J. J. van der Vliet;B. Mary E. von Blomberg;Mette D. Hazenberg;Nobusuke Nishi

  • Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM.

    Femke A.E. Lambers;Maria Prins;Xiomara Thomas;Richard Molenkamp

  • Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

    Geert Robaeys;Geert Robaeys;Jason Grebely;Stefan Mauss;Philip Bruggmann

Frequent Co-Authors

Janke Schinkel
Janke Schinkel University of Amsterdam
Margaret Hellard
Margaret Hellard Burnet Institute
Roel A. Coutinho
Roel A. Coutinho University Medical Center Utrecht
Peter Reiss
Peter Reiss University of Amsterdam
R. A. Coutinho
R. A. Coutinho University of Amsterdam
Gregory J. Dore
Gregory J. Dore University of New South Wales
Jason Grebely
Jason Grebely University of New South Wales
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
Lisa Maher
Lisa Maher University of New South Wales
Andrea L. Cox
Andrea L. Cox Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related nursing degrees can open diverse career opportunities. Many professionals consider advancing to a Doctor of Nursing Practice (DNP), with salaries varying by geography. Understanding how much does a dnp make in different states helps in planning long-term career goals.

Specializing further is also an option, such as achieving acute care nurse practitioner certification. This certification allows nurses to work in critical care settings, expanding the scope of practice and potential impact on patient care, particularly in immunology-related acute cases.

For those aiming to fast-track their education, enrolling in an accelerated fnp program can provide a quicker pathway to becoming a Family Nurse Practitioner, which can complement immunology knowledge with primary healthcare skills.

Individuals without a nursing background can also begin their journey through online rn programs for non nurses in florida. These programs offer accessible entry points into nursing, which can later lead to specialization in immunology.

Best Scientists Citing Maria Prins

Trending Scientists

Recently Published Articles